مواقع التدريسيينجامعة الكوفة
Karrar Talib Khudhair Albo Hamrah
Assistant Professor

Karrar Talib Khudhair Albo Hamrah

0Publications
0Lectures
0Interests

About

Graduated from the Faculty of Pharmacy / University of Kufa in 2007 and the owner of the Ministry of Health in 2008 and then transferred to higher education and scientific research in 2012
MA in Baghdad University / Faculty of Pharmacy in 2014 and then graduated in 2017 and I am still working in the Faculty of Pharmacy / University of Kufa

Research Interests

1

Publications

2
2016

A study on some variables that affect the characteristic features of floating microspheres of lafutidine

Authorsمدرس ايمان بكر حازم , م.م كرار طالب خضير
JournalInternational journals of pharmaceutics science review and research
Abstract

A study on some variables that affect the characteristic features of floating microspheres of lafutidine

2024

PREPARATION AND EVALUATION OF LAFUTIDINE NANOEMULSION AS ORAL DELIVERY SYSTEM

AuthorsKARRAR T. KHUDHAIR ALBO HAMRAH, ABULFADHEL J. NEAMAH AL-SHAIBANI,INAS F. ABDULRAZZAQ
JournalInt J App Pharm
Date2024-03-06
Abstract

ABSTRACT Objective: Lafutidine is a histamine (H2) receptor antagonist utilized for the treatment of gastric ulcer. Its oral bioavailability is low due to poor water solubility and an extensive first-pass hepatic. So, the present work aims to formulate and characterize of an oil in water (o/w) nanoemulsion of lafutidine as oral liquid dosage form and this could enhance drug solubility and improve its bioavailability. Methods: The pseudo-ternary phase diagrams were constructed via titration method. The diagram plots derived from oil, various ratios of surfactant and co-surfactant (S mix), and double distilled water. The selected optimized lafutidine nanoemulsions formula was determined via a variety of investigational studies like particle size, polydispersity index (PDI), zeta potential, pH, drug content and an in vitro drug release. Results: Characterization studies revealed that the optimum formula of nanoemulsions was (NE5), which consist of 0.2% of lafutidine, 30 % of surfactant and co-surfactant (S mix) (3:1), which mean (22.5%of tween 20:7.5% of polyethylene glycol 200 (PEG 200), 10% of peppermint oil and 59.4% of double distilled water. The optimized formula exhibited droplets size (62.56-96.2 nm), PDI (0.11), good pH value (7.1), zeta potential (-32.2 mV), high drug content (99.2%), in vitro release of lafutidine was significantly higher (P<0.05) for NE5. Scanning probe microscopy (SPM) revealed that the droplets size of NE5 was in nano-scale. Conclusion: It is possible to conclude that the optimized formula (NE5) was promised formula of nanoemulsion for increasing the orally delivered lafutidine bioavailability. Keywords: Nano emulsion, Solubility, Pseudo-ternary phase diagram, Lafutidine

Lectures

2
View details